Chorea

Continuum (Minneapolis, Minn.)
|August 7, 2016
PubMed

Insights

Diagnosing adult chorea is complex. A detailed history is crucial, and C9orf72 gene mutations are a new consideration for neurodegenerative chorea after excluding Huntington disease.

Area of Science:

  • Neurology
  • Genetics
  • Clinical Medicine

Background:

  • Chorea is a hyperkinetic movement disorder with diverse etiologies.
  • Huntington disease (HD) is a primary consideration in adult-onset chorea.
  • Differentiating chorea requires a systematic clinical approach.

Purpose of the Study:

  • To review the clinical diagnosis of adult chorea.
  • To highlight diagnostic elements and management principles.
  • To discuss chorea in the context of neurodegenerative syndromes.

Main Methods:

  • Clinical review of diagnostic approaches to chorea.
  • Emphasis on detailed patient history and associated findings.
  • Integration of genetic testing considerations.

Main Results:

  • C9orf72 gene mutations are a significant cause of Huntington disease phenocopies in white populations.
  • Diagnosis of chorea is challenging due to multiple potential causes.
  • No novel disease-modifying treatments for chorea or neurodegenerative choreic syndromes exist.

Conclusions:

  • A thorough patient history is essential for diagnosing chorea.
  • Consideration of C9orf72 gene mutations is recommended for neurodegenerative chorea, post-Huntington disease exclusion.
  • Current treatments for chorea primarily involve symptomatic management with dopamine blockers or tetrabenazine.
Abstract

Related Concept Videos

Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
716
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.3K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
7.0K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.7K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K